Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Chren

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
The British Journal of Dermatology|June 19, 2016
Is screening for basal cell carcinoma worthwhile? Too soon to tellE Linos, M-M Chren
JAMA|March 2, 1994
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formularyM M Chren, C S Landefeld
Journal of General Internal Medicine|October 1, 1996
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of viewC S Landefeld, M M Chren
JAMA|December 28, 1994
A cost analysis of topical drug regimens for dermatophyte infectionsM M Chren, C S Landefeld
The British Journal of Dermatology|June 6, 2017
Patients' reports as indicators of quality of careM P Dizon, M-M Chren
Archives of Dermatology|April 29, 1998
Acne vulgaris and the quality of life of adult dermatology patientsR J Lasek, M M Chren
Rhode Island Medical Journal|December 1, 1991
Doctors, drug companies and giftsM M Chren, C S Landefeld
Journal of the American Geriatrics Society|October 20, 1998
Preventing disability in older people with chronic disease: what is a doctor to do?C S Landefeld, M M Chren
The British Journal of Dermatology|March 1, 2017
More than skin-deep: is basal cell carcinoma a marker for a cancer-prone phenotype?E Linos, S Bhatia, M M Chren
International Journal of Dermatology|January 1, 1996
Fat necrosis with features of erythema nodosum in a patient with metastatic pancreatic carcinomaF M Durden, E Variyam, M M Chren
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The British Journal of Dermatology|June 19, 2016
Is screening for basal cell carcinoma worthwhile? Too soon to tellE Linos, M-M Chren
JAMA|March 2, 1994
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formularyM M Chren, C S Landefeld
Journal of General Internal Medicine|October 1, 1996
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of viewC S Landefeld, M M Chren
JAMA|December 28, 1994
A cost analysis of topical drug regimens for dermatophyte infectionsM M Chren, C S Landefeld
The British Journal of Dermatology|June 6, 2017
Patients' reports as indicators of quality of careM P Dizon, M-M Chren
Archives of Dermatology|April 29, 1998
Acne vulgaris and the quality of life of adult dermatology patientsR J Lasek, M M Chren
Rhode Island Medical Journal|December 1, 1991
Doctors, drug companies and giftsM M Chren, C S Landefeld
Journal of the American Geriatrics Society|October 20, 1998
Preventing disability in older people with chronic disease: what is a doctor to do?C S Landefeld, M M Chren
The British Journal of Dermatology|March 1, 2017
More than skin-deep: is basal cell carcinoma a marker for a cancer-prone phenotype?E Linos, S Bhatia, M M Chren
International Journal of Dermatology|January 1, 1996
Fat necrosis with features of erythema nodosum in a patient with metastatic pancreatic carcinomaF M Durden, E Variyam, M M Chren
Pageof 7